GoodRx Holdings (GDRX) Free Cash Flow (2019 - 2026)
GoodRx Holdings' Free Cash Flow history spans 7 years, with the latest figure at $18.3 million for Q4 2025.
- On a quarterly basis, Free Cash Flow fell 58.95% to $18.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $97.4 million, a 46.67% decrease, with the full-year FY2025 number at $97.4 million, down 46.67% from a year prior.
- Free Cash Flow hit $18.3 million in Q4 2025 for GoodRx Holdings, down from $20.6 million in the prior quarter.
- Over the last five years, Free Cash Flow for GDRX hit a ceiling of $86.5 million in Q3 2024 and a floor of $3.4 million in Q4 2023.
- Historically, Free Cash Flow has averaged $30.4 million across 5 years, with a median of $26.0 million in 2021.
- Biggest five-year swings in Free Cash Flow: crashed 79.66% in 2023 and later skyrocketed 1209.28% in 2024.
- Tracing GDRX's Free Cash Flow over 5 years: stood at $23.7 million in 2021, then dropped by 29.34% to $16.7 million in 2022, then crashed by 79.66% to $3.4 million in 2023, then skyrocketed by 1209.28% to $44.6 million in 2024, then plummeted by 58.95% to $18.3 million in 2025.
- Business Quant data shows Free Cash Flow for GDRX at $18.3 million in Q4 2025, $20.6 million in Q3 2025, and $49.2 million in Q2 2025.